CCCatherine Chirouze

Catherine Chirouze

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Catherine Chirouze has a total of 348 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Interest of Follow-Up Radiological Imaging in Patients with Pyogenic Vertebral Osteomyelitis

    by Sophie Hecquet, Frank Verhoeven, Sébastien Aubry, Clément Prati, Daniel Wendling, Catherine Chirouze, Kévin Bouiller

    No recommendations are established for monitoring pyogenic vertebral osteomyelitis (PVO). Thus, the realization of systematic follow-up radiological imaging is controversial. The objective of this study was to evaluate the interest in follow-up radiological imaging in patients with PVO. We conducted a retrospective cohort analysis of patients with PVO who had both baseline and follow-up radiological imaging. We classified the follow-up images into two groups, improvement/stability, and deterioration, compared with the baseline data. For each patient, we compared their radiological imaging follow-up to their clinical-biological condition assessed at the same time. Eighty-six patients were included. The mean age was 68 years (±13). A total of 99 radiological imaging examinations at diagnosis and at follow-up were analyzed, 69 Magnetic Resonance Imaging (MRI), and 30 Computerized Tomography (CT scans). The mean delay between the follow-up radiological imaging and clinical evaluation was 2.8 +/− 2.1 months. Of the 36 patients with clinical and biological recovery, 24 patients (67%) had improved radiological imaging and 12 patients (34%) had radiological worsening (new abscesses (n = 4), extension of soft tissue infiltration (n = 2) and/or epiduritis (n = 2) or appearance of new locations (n = 1)). Among the 50 patients considered as unhealed, on the contrary, radiological imaging showed an improvement in imaging in 39 patients (78%) and a worsening in 11 patients (22%). Our study showed that there was no correlation between the clinical condition of patients and their follow-up radiological imaging in the context of PVO.


  • Open Access

    Human Infection of Methicillin-Susceptible Staphylococcus aureus CC398: A Review

    by Kevin Bouiller, Xavier Bertrand, Didier Hocquet, Catherine Chirouze

    Staphylococcus aureus (SA) belonging to the clonal complex 398 (CC398) took a special place within the species due to its spread throughout the world. SA CC398 is broadly separated in two subpopulations: livestock-associated methicillin-resistant SA (MRSA) and human-associated methicillin-susceptible SA (MSSA). Here, we reviewed the global epidemiology of SA CC398 in human clinical infections and focused on MSSA CC398. The last common ancestor of SA CC398 was probably a human-adapted prophage φSa3-positive MSSA CC398 strain, but the multiple transmissions between human and animal made its evolution complex. MSSA and MRSA CC398 had different geographical evolutions. Although MSSA was present in several countries all over the world, it was mainly reported in China and in France with a prevalence about 20%. MSSA CC398 was frequently implicated in severe infections such as bloodstream infections, endocarditis, and bone joint infections whereas MRSA CC398 was mainly reported in skin and soft tissue. The spread of the MSSA CC398 clone is worldwide but with a heterogeneous prevalence. The prophage φSa3 played a crucial role in the adaptation to the human niche and in the virulence of MSSA CC398. However, the biological features that allowed the recent spread of this lineage are still far from being fully understood.


  • Open Access

    Utility of CT scan in patients with initial negative PCR for SARS-CoV2: a report of three cases

    by Kevin Bouiller, Sébastien Humbert, Camille Payet-Revest, Anne-Sophie Brunel, Adrien Mareshal, Quentin Lepiller, Franck Grillet, Catherine Chirouze

    PCR-based viral RNA to confirm the diagnosis of SARS-CoV-2 infection has a sensitivity of around 70%. We report three cases of patients with negative initial PCR and CT scan lesions that led us to suspect COVID-19, but which one(s) are really COVID-19?


  • Serial use of pentamidine and miltefosine for treating Leishmania infantum-HIV coinfection

    by Jean-François Faucher, David Morquin, Jacques Reynes, Catherine Chirouze, Bruno Hoen, Vincent Le Moing


  • Open Access

    Reply to Biteker et al

    by Catherine Chirouze, François Alla, Bruno Hoen

    To the Editor—We thank Biteker et al for their comments [1]. Our study was not designed to determine the best timing of surgery in Staphylococcus aureus prosthetic valve infective endocarditis. Let us specify that we did not evaluate the benefit of surgery performed in the first 7 days of antibiotic therapy. We defined “early valve surgery” as a valve surgery performed during the hospital stay for infective endocarditis, according to the definition used in the most recent studies on this subject. We showed that in the postoperative period (7 days), the potential benefit of surgery was counterbalanced by the postoperative mortality.

  • Open Access

    Impact of Early Valve Surgery on Outcome of Staphylococcus aureus Prosthetic Valve Infective Endocarditis: Analysis in the International Collaboration of Endocarditis–Prospective Cohort Study

    by Catherine Chirouze, Vance G. Fowler, Daniel J. Sexton, G. Ralph Corey, Vivian H. Chu, Andrew Wang, Marie-Line Erpelding, Emanuele Durante-Mangoni, Efthymia Giannitsioti, Margaret M. Hannan, et al.

    Background. The impact of early valve surgery (EVS) on the outcome of Staphylococcus aureus (SA) prosthetic valve infective endocarditis (PVIE) is unresolved. The objective of this study was to evaluate the association between EVS, performed within the first 60 days of hospitalization, and outcome of SA PVIE within the International Collaboration on Endocarditis–Prospective Cohort Study. Methods. Participants were enrolled between June 2000 and December 2006. Cox proportional hazards modeling that included surgery as a time-dependent covariate and propensity adjustment for likelihood to receive cardiac surgery was used to evaluate the impact of EVS and 1-year all-cause mortality on patients with definite left-sided S. aureus PVIE and no history of injection drug use. Results. EVS was performed in 74 of the 168 (44.3%) patients. One-year mortality was significantly higher among patients with S. aureus PVIE than in patients with non–S. aureus PVIE (48.2% vs 32.9%; P = .003). Staphylococcus aureus PVIE patients who underwent EVS had a significantly lower 1-year mortality rate (33.8% vs 59.1%; P = .001). In multivariate, propensity-adjusted models, EVS was not associated with 1-year mortality (risk ratio, 0.67 [95% confidence interval, .39–1.15]; P = .15). Conclusions. In this prospective, multinational cohort of patients with S. aureus PVIE, EVS was not associated with reduced 1-year mortality. The decision to pursue EVS should be individualized for each patient, based upon infection-specific characteristics rather than solely upon the microbiology of the infection causing PVIE.


  • Infective Endocarditis Epidemiology and Consequences of Prophylaxis Guidelines Modifications: the Dialectical Evolution

    by C. Chirouze, B. Hoen, X. Duval

    Historically, infective endocarditis (IE) affected patients with predisposing cardiac conditions and community-acquired bacteremia. Over the past 30 years, significant changes have occurred, regarding microorganisms, underlying valvular heart diseases, portals of entry, and patients’ comorbidities. Given these epidemiological changes and unproven prophylaxis efficacy, experts in most countries currently limit antibiotic indications to patients with high-risk cardiac conditions having oral procedures and, in the UK, recommend discontinuing their use altogether. To date, no epidemiological impact on streptococcal IE incidence has been observed. Policy must now address these epidemiological modifications, focus on community-acquired and health care-associated staphylococcal bacteremia prevention, and prompt the adoption of broader and nonexclusively antibiotic-based strategies.


  • Penetration of Daptomycin into Bone and Synovial Fluid in Joint Replacement

    by D. Montange, F. Berthier, G. Leclerc, A. Serre, L. Jeunet, M. Berard, P. Muret, L. Vettoretti, J. Leroy, B. Hoen, et al.

    Daptomycin exhibits clinical activity in the treatment of infections with Gram-positive organisms, including infections due to methicillin-resistant Staphylococcus aureus . However, little is known about its penetration into bone and synovial fluid. The aim of our study was to assess the penetration of daptomycin into bone and synovial fluid after a single intravenous administration. This study was conducted in 16 patients who underwent knee or hip replacement and received a single intravenous dose of 8 mg of daptomycin per kg of body weight prior to surgery. Plasma daptomycin concentrations were measured 1 h after the end of daptomycin infusion and when bone fragments were removed. Daptomycin concentrations were also measured on bone fragments and synovial fluid collected at the same time during surgery. All samples were analyzed with a diode array–high-performance liquid chromatography (HPLC) method. After a single-dose intravenous infusion, bone daptomycin concentrations were above the MIC of daptomycin for Staphylococcus aureus in all subjects, and the median bone penetration percentage was 9.0% (interquartile range [IQR], 4.4 to 11.4). These results support the use of daptomycin in the treatment of Staphylococcus aureus bone and joint infections.


  • Open Access

    Evolving epidemiology and antimicrobial resistance in spontaneous bacterial peritonitis: a two-year observational study

    by Lionel Piroth, André Pechinot, Vincent Di Martino, Yves Hansmann, Alain Putot, Isabelle Patry, Tahar Hadou, Benoit Jaulhac, Catherine Chirouze, Christian Rabaud, et al.

    Current recommendations for empirical antimicrobial therapy in spontaneous bacterial peritonitis (SBP) are based on quite old trials. Since microbial epidemiology and the management of patients have changed, whether these recommendations are still appropriate must be confirmed.


  • Open Access

    Enterococcal endocarditis in the beginning of the 21st century: analysis from the International Collaboration on Endocarditis-Prospective Cohort Study

    by C. Chirouze, E. Athan, F. Alla, V.H. Chu, G. Ralph Corey, C. Selton-Suty, M.-L. Erpelding, J.M. Miro, L. Olaison, B. Hoen